Bayer faces second investor reckoning over glyphosate litigation

[ad_1]
Bayer on Tuesday faces its second annual investor reckoning over its handling of a wave of U.S. lawsuits claiming its glyphosate-based weedkillers cause cancer.

[ad_2]
Source link